Intuitive Surgical, Inc. vs Snap On Incorporated — how do they compare? Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B), while Snap On Incorporated trades at $360.37 (market cap $18.56B). The key difference: Intuitive Surgical, Inc. is far larger — about 7.9× Snap On Incorporated's market cap, and Snap On Incorporated pays a 2.72% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Snap On Incorporated for 37 Days on average.
| ISRG | SNA | |
|---|---|---|
Market Cap | $146.76B | $18.56B |
Volume | 2,529,814 | 401,326 |
Sector | Health | Industrials |
52-Week High | $592.85 | $419.31 |
52-Week Low | $332.02 | $327.33 |
Typical Hold Time | 84 Days | 37 Days |
Enterprise Value | $141.54B | $18.20B |
Dividend Yield | — | 2.72% |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.80, and has shown consistent revenue growth, reaching $10.06B in 2025. Analyst consensus is strongly bullish with a $480.78 price target, though the stock faces headwinds from slower procedure growth in some markets.
The outlook for ISRG remains positive due to its dominant position in robotic surgery, expanding international presence, and high recurring revenue. Key risks include competitive pressures, regulatory hurdles, and economic sensitivity affecting procedure volumes. With solid fundamentals and analyst support, the stock offers growth potential, but investors should monitor execution against these risks.
Snap-On Incorporated (SNA) trades at $358.88, down 0.28% on the day, with a bearish technical signal from moving averages and oscillators. The company reported solid fundamentals with a 19.6% net income margin and a 17.58% ROE for 2025. Recent earnings show a mix of beats and a miss, with Q3 2026 results pending. Analyst consensus is bullish with a $449 price target, but technical indicators suggest near-term caution amid institutional position adjustments.
The outlook for SNA is supported by strong profitability and analyst optimism, but faces headwinds from technical bearishness and valuation risks. Investment opportunity lies in execution of RCI initiatives and diagnostic segment growth, while risks include integration costs from acquisitions and softer OEM demand. The stock's premium valuation requires sustained earnings growth to justify further upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →